Psychotropic drug use in aged care facilities: a reflection of a systemic problem?

Jeffrey C L Looi and Stephen Macfarlane
Med J Aust 2014; 200 (1): . || doi: 10.5694/mja13.10469
Published online: 20 January 2014

Pharmacological therapy is only part of the answer to improving mental health

Summary of the issues surrounding psychotropic drug use in residential aged care facilities (RACFs)

  • Jeffrey C L Looi1
  • Stephen Macfarlane2,3

  • 1 Research Centre for the Neurosciences of Ageing, Academic Unit of Psychiatry and Addiction Medicine, Australian National University Medical School, Canberra, ACT.
  • 2 Aged Psychiatry, Monash University, Melbourne, VIC.
  • 3 Caulfield Aged Psychiatry Service, Melbourne, VIC.



We thank Daniel O’Connor, Roderick McKay and Gerard Byrne, executive members of the Faculty of Psychiatry of Old Age, Royal Australian New Zealand College of Psychiatrists (RANZCP) for discussing with us the issues covered in this article.

Competing interests:

We are both executive members of the Faculty of Psychiatry of Old Age, RANZCP. The views expressed in this article are our own and not those of the RANZCP. Stephen Macfarlane has received speaker’s honoraria from Eli Lilly, Janssen-Cilag, Pfizer and Lundbeck, and a Lundbeck Fellowship to attend a series of seminars on dementia held at the Lundbeck Institute in Skodsborg, Denmark, in 2009.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.